Accredo offers a wide range of medications to treat various complex and chronic conditions. Visit Conditions to learn more about treatment, medications, and support for your condition.
| Medication | Condition(s) | Generic/Biosimilar | Manufacturer |
|---|---|---|---|
| Phesgo™ (pertuzumab, trastuzumab, and hyaluronidase-zzxf) |
Breast cancer
|
Genentech USA, Inc. | |
| PiaSky™ (crovalimab-akkz) |
Paraoxysmal nocturnal hemoglobinuria (PNH)
|
Genentech | |
| Pifeltro™ (doravirine) | Merck & Co., Inc. | ||
| Plegridy® (peginterferon beta-1a) | Biogen, Inc. | ||
| Polivy™ (polatuzumab vedotin-piiq) |
Lymphoma
|
Genentech USA, Inc. | |
| Pomalyst® (pomalidomide) |
Myeloma
|
Generic(s) Available | Celgene Corporation |
| Pombiliti™ (cipaglucosidase alfa-atga) + Opfolda™ (miglustat) | Amicus Therapeutics | ||
| Ponvory® (ponesimod) | Vanda Pharmaceuticals, Inc. | ||
| Portrazza® (necitumumab) |
Lung cancer
|
Eli Lilly & Co. | |
| Pregnyl® (chorionic gonadatropin) | Merck & Co., Inc. |